Stay updated on Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.

Latest updates to the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page
- Check2 days agoChange DetectedThe web page has added a section with helpful links provided by the Humanitas Mirasole SpA TUDCA-ALS Consortium, enhancing the resourcefulness of the page.SummaryDifference0.4%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a Phase III clinical trial for TUDCA in ALS patients, while retaining the mention of ALS and the EudraCT number. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference24%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.14.3, indicating a new revision, while the previous version 2.14.2 has been removed. Additionally, a section titled 'Helpful Links Provided by Humanitas Mirasole SpA TUDCA-ALS Consortium website' has been deleted.SummaryDifference0.6%
- Check53 days agoChange DetectedDifference0.1%
Stay in the know with updates to Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.